-
-
Monthly buprenorphine injections effective for opioid use disorders (February 19, 2019)
Study results on long-acting injection formulation now published. -
-
-
Study shows impact of social interactions on addictive behavior (October 15, 2018)
Science Spotlight. -
2018 Avenir award recipient to study how social networks affect people who use drugs (July 02, 2018)
Announcement. -
Training module now available for acute pain management in hospitalized adults (June 27, 2018)
New online course is 10th in a series developed by the NIH Pain Consortium. -
Analysis of insurance coverage for back pain shows missed opportunities to prescribe non-opioid medications (June 22, 2018)
Science Spotlight. -
Methadone and buprenorphine reduce risk of death after opioid overdose (June 19, 2018)
NIH research confirms effective treatments for opioid use disorder are underutilized. -
-
Study upends conventional view of opioid mechanism of action (May 10, 2018)
NIH-funded scientists find new molecular target for developing safer pain medications. -
-
Dr. Kurt Rasmussen to lead NIDA’s therapeutics and medical consequences division (April 30, 2018)
Brings expertise in neuroscience therapeutics. -
Study changes long-held concepts of cell decoding (March 28, 2018)
NIH scientists discover macromolecular complexes that could enable medication development. -
-
Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release (February 14, 2018)
Science Spotlight. -
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development (January 04, 2018)
Science Spotlight. -
Opioid treatment drugs have similar outcomes once patients initiate treatment (November 14, 2017)
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone. -
-
Medication plus ongoing care provided in emergency departments is promising approach for opioid dependence (February 23, 2017)
Science Spotlight. -
Multi agency funding announcement to assist with opioid crisis in rural U.S. regions (October 07, 2016)
Announcement. -
Buprenorphine Prescribers Treat Below Current Patient Limits (September 20, 2016)
Science Spotlight. -
Recruitment begins for landmark study of adolescent brain development (September 13, 2016)
More than 10,000 children will participate in study of brain, social, emotional, and cognitive development. -
-
-
Co-prescribing naloxone in primary care settings may reduce ER visits (June 28, 2016)
Science Spotlight. -
Addiction treatment patients trained to manage their healthcare may have better outcomes (June 22, 2016)
Science Spotlight. -
Pioneering early stage researchers selected for NIDA’s 2016 Avenir awards (June 09, 2016)
Awards recognize cutting edge HIV/AIDS and epigenetics research. -
-